Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD

Gabriella Long, Jasmine Wall
Breathe 2018 14: 338-341; DOI: 10.1183/20734735.026318
Gabriella Long
1University of Manchester, Manchester University Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriella Long
  • For correspondence: gabriella.long@postgrad.manchester.ac.uk
Jasmine Wall
2Bolton NHS Foundation Trust, Bolton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jasmine Wall
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 14 no. 4 338-341
DOI 
https://doi.org/10.1183/20734735.026318

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Published online November 30, 2018.

Copyright & Usage 
Copyright ©ERS 2018 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Gabriella Long1⇑ and
  2. Jasmine Wall2
  1. 1University of Manchester, Manchester University Foundation Trust, Manchester, UK
  2. 2Bolton NHS Foundation Trust, Bolton, UK
  1. E-mail: gabriella.long{at}postgrad.manchester.ac.uk
View Full Text

Article usage

Article usage: November 2018 to April 2023

AbstractFullPdf
Nov 20180101
Dec 20182453116
Jan 2019512936
Feb 201938336
Mar 201966521
Apr 201934924
May 201946020
Jun 201953513
Jul 201943214
Aug 20195225
Sep 20191397
Oct 20193307
Nov 201953413
Dec 20191184
Jan 202015228
Feb 202024642
Mar 202044936
Apr 202024012
May 202054321
Jun 20203289
Jul 20202149
Aug 20201327
Sep 20200264
Oct 2020113138
Nov 20202339
Dec 202084410
Jan 20214439
Feb 202112911
Mar 20211356
Apr 20212469
May 20213269
Jun 20212219
Jul 202111413
Aug 20212193
Sep 202112912
Oct 202134529
Nov 202107829
Dec 2021122210
Jan 20226528
Feb 20222371
Mar 20223485
Apr 202212910
May 202234713
Jun 20221114
Jul 20221132
Aug 20221247
Sep 202213114
Oct 20223199
Nov 202205810
Dec 202211819
Jan 20236326
Feb 20230575
Mar 20230184
Apr 202301510

Altmetrics

PreviousNext
Back to top
Vol 14 Issue 4 Table of Contents
Breathe: 14 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
Gabriella Long, Jasmine Wall
Breathe Dec 2018, 14 (4) 338-341; DOI: 10.1183/20734735.026318

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
Gabriella Long, Jasmine Wall
Breathe Dec 2018, 14 (4) 338-341; DOI: 10.1183/20734735.026318
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • Study design
    • Key results
    • Strengths and limitations
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Journal club

  • Impact of triple therapy on mortality in COPD
  • CPAP for secondary cardiovascular prevention in OSA patients
  • Maternal vaccination during pregnancy against infant respiratory viruses
Show more Journal club

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society